Retatrutide Peptide – 10 mg / 20mg / 30mg
Purity: 99.644% / 99.350% / 99.27%
Product Information
- Common Name: Retatrutide (LY3437943)
- CAS Number: 2381089-83-2
- Content: 11.41mg Retatrutide peptide
- Content: 23.03mg Retatrutide peptide
- Content: 32.15mg Retatrutide peptide
- Packaging: Sealed under vacuum or filled with inert gas to maintain stability
Physical Characteristics
- Form: White/Silver lyophilized powder
- Solution Colour: Clear after reconstitution
Solubility
- Water soluble
- Commonly reconstituted with sterile water
Storage Recommendations
- Store away from direct sunlight and UV exposure
- Long-term storage: Freezer recommended
- Short-term storage: Refrigerator
- Avoid repeated freeze–thaw cycles
- Once reconstituted: refrigerate only and do not freeze
Mixing Reference
10mg
- 1 ml sterile water = 10 × 0.1 ml portions (1 mg per 0.1 ml)
- 2 ml sterile water = 20 × 0.1 ml portions (0.5 mg per 0.1 ml)
- Measurement reference:
- 1 mg = 1,000 mcg
20mg
- 2 ml sterile water = 10 × 0.2 ml portions (2 mg per 0.2 ml)
- 2 ml sterile water = 20 × 0.1 ml portions (1 mg per 0.1 ml)
- Measurement reference:
- 1 mg = 1,000 mcg
30mg
- 3 ml sterile water = 10 × 0.3 ml portions (3 mg per 0.3 ml)
- 3 ml sterile water = 30 × 0.1 ml portions (1 mg per 0.1 ml)
- Measurement reference:
- 1 mg = 1,000 mcg
Disclaimer
This product is not:
- Intended to diagnose, treat, cure, or prevent any disease
- A dietary or sports supplement
- Approved for human use
- An injectable medication
For research and laboratory use only.
| Researched for: | Retatrutide is an investigational peptide medication being developed by Eli Lilly and Company. It is designed to treat metabolic diseases by targeting three hormone systems at once, making it one of the most advanced drugs currently being studied for obesity and metabolic health. Retatrutide is often described as a “triple-agonist” because it activates receptors for: Glucagon-like peptide-1 Glucose-dependent insulinotropic polypeptide Glucagon This combination affects appetite, blood sugar, and energy expenditure simultaneously. 1. Obesity and Weight Loss The main research focus is treating Obesity. Retatrutide may help people lose weight through several mechanisms: suppressing appetite (GLP-1 effects) improving insulin and metabolic signalling (GIP) increasing calorie burning and fat metabolism (glucagon) In early clinical trials, participants lost around 20–24% of body weight after about 48 weeks, one of the largest effects seen in a weight-loss drug study. 2. Type 2 Diabetes Like other incretin-based drugs, Retatrutide is being studied for Type 2 Diabetes. Research suggests it may: increase insulin release when glucose is high lower blood sugar levels improve insulin sensitivity reduce HbA1c Because it targets three metabolic pathways, scientists think it could potentially outperform older drugs that target only one. 3. Fatty Liver Disease Another area of research is Metabolic Dysfunction-Associated Steatotic Liver Disease. Studies show Retatrutide may: significantly reduce liver fat improve metabolic markers reduce inflammation in the liver In one study, liver fat dropped by over 80% in some participants at higher doses. 4. Cardiovascular and Metabolic Health Because obesity and diabetes increase heart risk, researchers are studying Retatrutide's effects on: blood pressure cholesterol heart disease risk kidney health This relates to conditions like Cardiovascular disease. Large outcome trials are currently underway. 5. Other Conditions Being Studied Ongoing clinical trials are exploring whether Retatrutide could help with: Obstructive Sleep Apnoea Osteoarthritis chronic low back pain linked to obesity These studies are investigating whether weight loss and metabolic improvements reduce symptoms |
|---|
Only logged in customers who have purchased this product may leave a review.
Related products
Featured Product
Growth Hormone Support Research
Growth Hormone Support Research
Featured Product
Growth Hormone Support Research
Longevity & Cellular Health Research
Growth Hormone Support Research
Reviews
There are no reviews yet.